Education
About Us
Working with TipRanks
Follow Us
Allarity Therapeutics, Inc. (ALLR)
NASDAQ:ALLR
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -37.00K | $ -120.00K | $ -106.00K | $ -86.00K |
| Operating Income | $ -27.24M | $ -17.93M | $ -34.46M | $ -26.56M | $ -9.23M |
| EBITDA | $ -27.24M | $ -12.08M | $ -17.24M | $ -25.91M | $ -6.01M |
| Net Income | $ -24.52M | $ -11.90M | $ -16.06M | $ -26.65M | $ -5.07M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 19.53M | $ 166.00K | $ 2.03M | $ 19.55M | $ 298.00K |
| Total Assets | $ 22.65M | $ 11.86M | $ 14.54M | $ 49.63M | $ 33.40M |
| Total Debt | $ 1.35M | $ 1.30M | $ 3.73M | $ 1.09M | $ 1.79M |
| Net Debt | $ -18.18M | $ 1.13M | $ 1.71M | $ -18.47M | $ 1.49M |
| Total Liabilities | $ 10.84M | $ 14.61M | $ 12.65M | $ 30.85M | $ 6.55M |
| Stockholders' Equity | $ 11.81M | $ -2.75M | $ 1.89M | $ 18.78M | $ 26.85M |
| Cash Flow | |||||
| Free Cash Flow | $ -17.65M | $ -12.74M | $ -16.84M | $ -15.05M | $ -7.25M |
| Operating Cash Flow | $ -17.35M | $ -12.74M | $ -16.82M | $ -15.05M | $ -7.25M |
| Investing Cash Flow | $ -298.00K | $ 0.00 | $ 791.00K | $ 1.00M | $ -3.00K |
| Financing Cash Flow | $ 36.79M | $ 10.99M | $ -1.31M | $ 33.82M | $ 6.03M |
Allarity Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.